Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ramelteon Phase-Shifting Effects in Healthy Adults
NCT00671190Phase 2Completed
- Sponsor
- Takeda
- Start
- Mar 2005
- Primary completion
- May 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ramelteon in circadian rhythm sleep disorder (CRSD), sponsored by Takeda. Started Mar 2005; status: completed.
02
Drugs
ramelteon
03
Conditions
circadian rhythm sleep disorder (CRSD)
Beyond the preview
Go deeper on NCT00671190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00671190.